Investment Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$266K Buy
2,211
+61
+3% +$7.04K 0.07% 160
2025
Q4
$226K Buy
+2,150
New +$202K 0.06% 178
2025
Q2
Sell
-2,482
Closed -$223K 178
2025
Q1
$223K Sell
2,482
-36
-1% -$3.36K 0.07% 153
2024
Q4
$250K Buy
2,518
+25
+1% +$2.58K 0.08% 143
2024
Q3
$283K Buy
2,493
+413
+20% +$49.1K 0.1% 134
2024
Q2
$258K Sell
2,080
-13
-0.6% -$1.68K 0.1% 133
2024
Q1
$276K Buy
2,093
+30
+1% +$3.7K 0.11% 124
2023
Q4
$225K Sell
2,063
-276
-12% -$28.6K 0.1% 135
2023
Q3
$241K Buy
2,339
+4
+0.2% +$431 0.13% 116
2023
Q2
$269K Hold
2,335
0.14% 111
2023
Q1
$248K Sell
2,335
-63
-3% -$6.8K 0.14% 118
2022
Q4
$266K Hold
2,398
0.16% 108
2022
Q3
$207K Hold
2,398
0.14% 117
2022
Q2
$218K Buy
+2,398
New +$213K 0.15% 112

Other funds holding MRK

Investment Advisory Group's MRK Position: Q1 2026 in Review

Investment Advisory Group increased its Merck (MRK) stake by 2.8% in Q1 2026, buying an estimated $7.04K and bringing the position to 2,211 shares worth $266K. The position accounts for 0.07% of the portfolio, ranked #160.

Investment Advisory Group first reported a position in MRK in Q2 2022 and has held it in 14 quarters since. The position peaked at $283K in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Investment Advisory Group held 2,211 shares of Merck worth $266K as of Q1 2026.
  • Investment Advisory Group bought 61 Merck shares in Q1 2026, an estimated $7.04K.
  • Merck made up 0.07% of Investment Advisory Group's portfolio in Q1 2026, its #160 holding.
  • Investment Advisory Group first reported a position in Merck in Q2 2022 and has held it in 14 quarters since.
  • Investment Advisory Group's Merck position peaked at $283K in Q3 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Investment Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.